Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,489 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (403)

clinicaltrialsPublishedShowing 1,051–1,100 of 1,275 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03026803	A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer	terminated	Phase 2	4	City of Hope Medical CenterOTHER	1	Apr 13, 2017	clinicaltrials
NCT01125800	A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB	completed	Phase 1 / Phase 2	76	Novartis PharmaceuticalsINDUSTRY	6	Mar 20, 2017